GlassScriptPhysician profile
Melissa Oh
NPI 1528555430
$2,121.38
in general payments reported to CMS, 2019-2025
13 companies · $852 in 2025
The $852 reported for 2025 was more than what 76% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $171 · 2023: $84.47 · 2024: $1,014 · 2025: $852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,950.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $697.99 | 2024-2025 | Inspire |
| Aerin Medical INC. | $549.25 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $386.53 | 2023-2025 | Dupixent |
| Medtronic, INC. | $158.28 | 2022 | |
| Glaxosmithkline, LLC. | $97.59 | 2024-2025 | Nucala |
| Genzyme Corporation | $54.47 | 2024 | |
| Spirair, INC. | $39.08 | 2025 | |
| Stryker Corporation | $30.06 | 2025 | Scopis Ent |
| Depuy Synthes Sales INC. | $29.68 | 2023 | Matrixmidface |
| Cochlear Americas | $27.89 | 2024 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Optinose US, INC. | $22.81 | 2025 | |
| Merck Sharp & Dohme LLC | $15.24 | 2023 | |
| Karl Storz Endoscopy-America | $12.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Oh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.